Zacks

Zacks Small Cap Research – FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis… – Go Health Pro

by
Zacks Small Cap Research – FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis… – Go Health Pro

By David Bautz, PhD NASDAQ:FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society for Investigative Dermatology (SID) Annual Meeting. The poster entitled “Immunomodulatory Potential of Human Dermal Fibroblast Spheroids in Psoriasis Therapy” can … Read more

Zacks Small Cap Research – RERE 1Q25 Earnings Review: EPS Strength Beneath the Surface; Rising Trade-In Activity Increasingly Driving Growth – Go Health Pro

by

By Michael Kim NYSE:RERE READ THE FULL RERE RESEARCH REPORT Pre-market open on 5/20/25, ATRenew (NYSE:RERE) reported 1Q25 earnings results. On a GAAP basis, RERE reported net income of $5.9 million for 1Q25, or $0.02 per ADS. That said, excluding non-cash share-based compensation and intangible assets amortization expenses, adjusted EPS came in at $0.04, or … Read more

Zacks Small Cap Research – MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00 – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development expenses for the quarter were $2.26 million compared to $2.41 million in the prior year period. The R&D decrease was primarily … Read more

Zacks Small Cap Research – CXW: Believe CXW is Well-Positioned for Further Occupancy Increases – Go Health Pro

by
Zacks Small Cap Research – CXW: Believe CXW is Well-Positioned for Further Occupancy Increases – Go Health Pro

By M. Marin NYSE:CXW READ THE FULL CXW RESEARCH REPORT Reactivating idled facilities, as demand for occupancy is expected to rise CoreCivic (NYSE:CXW) reported 1Q25 compensated occupancy of 77.0%, up from 75.2% in 1Q24. Importantly, CXW is in the process of reactivating them, as well as one other idled facility. ICE is seeking to expand … Read more

Zacks Small Cap Research – DEFT: 1Q25 Earnings Review: Adjusted EPS Miss on Higher Expenses; Raising on EPS Estimates/Price Target on Accelerating Momentum across the Franchise – Go Health Pro

by

By Michael Kim NASDAQ:DEFT READ THE FULL DEFT RESEARCH REPORT Pre-market open on 5/14/25, DeFi Technologies (NASDAQ:DEFT) reported 1Q25 earnings results. On an IFRS basis, DEFT reported net income per share of $0.08, or meaningfully above our $0.04 estimate. While mark-to-market noise makes actual vs. estimate analysis a bit more challenging, we note core revenue … Read more